Legal Representation
Attorney
Aaron D. Hendelman
USPTO Deadlines
Next Deadline
2148 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2025-06-03)
Due Date
June 03, 2031
Grace Period Ends
December 03, 2031
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
32 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jun 3, 2025 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
| Jun 3, 2025 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| May 15, 2025 | SUNA | E | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | Loading... |
| May 15, 2025 | CNPR | P | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | Loading... |
| Apr 28, 2025 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Apr 28, 2025 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Apr 28, 2025 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Apr 11, 2025 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Feb 20, 2025 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Feb 20, 2025 | CNRT | W | SU - NON-FINAL ACTION - WRITTEN | Loading... |
| Feb 20, 2025 | GNRT | O | NON-FINAL ACTION E-MAILED | Loading... |
| Feb 11, 2025 | SUPC | I | STATEMENT OF USE PROCESSING COMPLETE | Loading... |
| Feb 10, 2025 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| Nov 27, 2024 | IUAF | S | USE AMENDMENT FILED | Loading... |
| Nov 27, 2024 | EISU | I | TEAS STATEMENT OF USE RECEIVED | Loading... |
| Jul 30, 2024 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Jun 4, 2024 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Jun 4, 2024 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| May 15, 2024 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| May 1, 2024 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Apr 25, 2024 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Apr 25, 2024 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Apr 25, 2024 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Mar 26, 2024 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Mar 26, 2024 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Mar 26, 2024 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Mar 21, 2024 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Feb 23, 2024 | TAEA | I | TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED | Loading... |
| Feb 23, 2024 | PARI | I | TEAS VOLUNTARY AMENDMENT RECEIVED | Loading... |
| Aug 15, 2023 | MDSM | E | NOTICE OF DESIGN SEARCH CODE E-MAILED | Loading... |
| Aug 13, 2023 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Jul 17, 2023 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Antibodies for medical purposes comprising oligonucleotide-conjugate based therapies, oligonucleotide-antibody conjugate based therapies, and oligonucleotide-antibody fragment conjugate based therapies for the treatment of viral diseases and disorders, endocrine diseases and disorders, musculoskeletal diseases and disorders, cardiovascular diseases and disorders, cardiopulmonary diseases and disorders, neuromuscular diseases and disorders, rare muscle diseases, cardiomyopathies diseases and disorders, heart muscle diseases, muscular dystrophies, muscle atrophy diseases and disorders, genitourinary diseases and disorders, sexual dysfunction, oncological diseases and disorders, hepatological diseases and disorders, ophthalmic diseases and disorders, respiratory diseases and disorders, neurological diseases and disorders, gastrointestinal diseases and disorders, hormonal diseases and disorders, dermatological diseases and disorders and psychiatric diseases and disorders, none of the aforementioned offerings being in the nature of dietetic substances for medical use, foods for special medical purposes, or special nutritional food products for medical purposes
First Use Anywhere:
20240800
First Use in Commerce:
20240800
Class 042
Providing medical and scientific research information in the fields of
pharmaceuticals and biotechnology
First Use Anywhere:
20240800
First Use in Commerce:
20240800
Additional Information
Design Mark
The mark consists of the EXPLORE text to the left of a 44 text inside of a partially full circle a top of a boat with 2 parallel wavy lines with one longer than the other at the bottom of the boat and a hyphen OLE text to the right.
Color Claim
Color is not claimed as a feature of the mark.
Pseudo Mark
EXPLORE FOUR FOUR OLE; EXPLORE FORTY FOUR OLE
Classification
International Classes
005
042